Skip to content

A randomized, double-blind, parallel controlled multi-center clinical study of fuzhiqing ointment for atopic dermatitis

A randomized, double-blind, parallel controlled multi-center clinical study of fuzhiqing ointment for atopic dermatitis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095971
Enrollment
Unknown
Registered
2025-01-15
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

Experimental Group:Fuzhiqing ointment
Control group:Placebo

Sponsors

Shanghai Skin Diseases Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: There is no gender limit, and the age is 18-60 years old; In line with the relevant diagnostic criteria in the guidelines for primary diagnosis and treatment of atopic dermatitis (2022), and in line with mild and moderate grades; The skin lesions accounted for less than 10% of the body surface area before treatment; The skin lesions should be located on the limbs or trunk as far as possible; Sign the informed consent form, voluntarily participate in this project, and adhere to the regular follow-up as required.

Exclusion criteria

Exclusion criteria: Pregnant women; Have received systemic treatment for ad within three months and local treatment or phototherapy within the past two weeks; Allergy to study drugs; Suffering from systemic diseases or active skin diseases that may affect the evaluation of test results; There are scars, birthmarks, tattoos, sunburn and other factors affecting the evaluation of skin lesions; Participated in or was participating in other clinical studies within one month; Have communication difficulties and cannot complete the case report form independently.

Design outcomes

Primary

MeasureTime frame
EASI;

Secondary

MeasureTime frame
Numerical Rating scale;investigator's global assessment;dermatology life quality index;

Countries

China

Contacts

Public ContactRuiping Wang

Shanghai Skin Diseases Hospital

w19830901@126.com+86 138 1684 5803

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026